Who has invested in Arcus Biosciences?

GV are named among the investors backing Arcus Biosciences.

Arcus Biosciences Funding: $227M Raised, Series C (2017)

Arcus Biosciences funding overview

Arcus Biosciences is based in Hayward. Arcus Biosciences has raised $227M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in November 2017. The round record for Arcus Biosciences runs through 2017; nothing later has been disclosed. Investors on record include GV.

Arcus Biosciences at a glance

Total raised: $227M
Latest round: Series C
Latest round date: November 2017
Headquarters: Hayward
Notable investors: GV

Frequently asked about Arcus Biosciences funding

How much has Arcus Biosciences raised?: Arcus Biosciences has raised $227M in total disclosed funding across the rounds on record.
Who has invested in Arcus Biosciences?: GV are named among the investors backing Arcus Biosciences.
What was the latest Arcus Biosciences funding round?: The most recent disclosed round is a Series C, announced in November 2017.
Where is Arcus Biosciences based?: Arcus Biosciences is based in Hayward.
When did Arcus Biosciences last raise?: The last disclosed Arcus Biosciences round closed in November 2017 at Series C.

Arcus Biosciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Hayward below to benchmark round size and investor mix.

Arcus Biosciences Funding: $227M Raised, Series C (2017)

Arcus Biosciences funding overview

Arcus Biosciences at a glance

Frequently asked about Arcus Biosciences funding

Companies related to Arcus Biosciences (29)

Browse related funding lists (4)